Reclassification and risk stratification of embolic stroke of undetermined source by ASCOD phenotyping

Takao Hoshino1, Takafumi Mizuno1, Ayako Nishimura1

  • 1Department of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.

Insights

Atherosclerosis, but not small-vessel disease or cardiac pathology, predicts recurrent vascular events in patients with embolic stroke of undetermined source (ESUS). ASCOD phenotyping aids risk prediction and management strategies for ESUS.

Area of Science:

  • Cardiovascular Medicine
  • Neurology
  • Vascular Biology

Background:

  • Embolic stroke of undetermined source (ESUS) can involve underlying vascular diseases like atherosclerosis, small-vessel disease (SVD), and cardioembolic pathology.
  • These common vascular conditions are not direct causes of stroke but contribute to risk.

Purpose of the Study:

  • To determine the frequency and severity of atherosclerosis, SVD, and cardiac pathology in ESUS patients using ASCOD phenotyping.
  • To evaluate the prognostic significance of these vascular diseases in ESUS.

Main Methods:

  • A prospective observational study enrolled 221 ESUS patients within one week of stroke onset.
  • Patients were followed for one year, with vascular diseases classified using the ASCOD system.
  • The primary outcome was a composite of nonfatal stroke, nonfatal acute coronary syndrome, and vascular death.

Main Results:

  • Atherosclerosis (ASCOD grade A2/A3) was present in 61.1% of patients and significantly increased the risk of vascular events (aHR 2.40).
  • Small-vessel disease (S3) and cardiac pathology (C2/C3) did not show a significant association with recurrent vascular events.
  • No significant differences in event risk were observed for SVD or cardiac pathology compared to their respective absence.

Conclusions:

  • Atherosclerotic diseases (ASCOD grade A2/A3) are predictive of recurrent vascular events in ESUS patients.
  • ASCOD phenotyping offers valuable insights for risk stratification and guiding management in ESUS.
  • This classification system can help refine treatment strategies for patients with ESUS.
Abstract